Skip to main content
Premium Trial:

Request an Annual Quote

ABI, Myriad Proteomics Pen R&D Collaboration

NEW YORK, Aug. 13 - Applied Biosystems and Myriad Proteomics today said they will collaborate to develop new proteomics technology.

 

The deal will employ the companies' existing capabilities, such as ABI's mass spectrometry and Myriad's experience with protein-protein interactions, to devise more effective ways of analyzing proteins and map the human proteome.

 

In the process ABI will have its 4700 protein analyzer put through its paces in hopes of tweaking its performance in protein-protein-interaction studies, said Stephen Martin, director of ABI's protein research center.

 

Participating in the collaboration will be scientists from ABI's Framingham, Wash., facility, and Myriad Proteomics' new space in Salt Lake City, the companies said. Myriad Proteomics was founded by Myriad Genetics, Oracle, Hitachi, and Friedli Corporate Finance.

 

Click here for more information.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.